1. Research UNE
  2. UNE
  3. Journal Article
Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/9702
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSharpley, Chrisen
dc.contributor.authorChristie, David R Hen
dc.date.accessioned2012-03-14T17:06:00Z-
dc.date.issued2011-
dc.identifier.citationOpen Prostate Cancer Journal, v.4, p. 1-5en
dc.identifier.issn1876-8229en
dc.identifier.urihttps://hdl.handle.net/1959.11/9702-
dc.description.abstractA common treatment for Prostate Cancer includes androgen-deprivation for a period of months prior to radiation or surgery. Some data suggest that this may exacerbate the already elevated depression levels of these patients, arguing for concomitant application of antidepressant therapy. However, the various waves of antidepressants developed in the last 40 years have shown only arguable specific efficacy over placebo, plus significant side-effects which may hinder treatment decision-making and compliance. This paper outlines two emerging and potential pathways for development of new pharmacological agents for depression that hold promise of helping patients to reduce their depressive symptomatology.en
dc.languageenen
dc.publisherBentham Openen
dc.relation.ispartofOpen Prostate Cancer Journalen
dc.titleThe HPA axis and GABA-Glutamate Systems as Potential Antidepressant Targets in Prostate Canceren
dc.typeJournal Articleen
dc.identifier.doi10.2174/1876822901104010001en
dc.subject.keywordsPsychiatry (incl Psychotherapy)en
local.contributor.firstnameChrisen
local.contributor.firstnameDavid R Hen
local.subject.for2008110319 Psychiatry (incl Psychotherapy)en
local.subject.seo2008920199 Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classifieden
local.profile.schoolSchool of Science and Technologyen
local.profile.schoolSchool of Science and Technologyen
local.profile.emailcsharpl3@une.edu.auen
local.profile.emaildchrist2@une.edu.auen
local.output.categoryC1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.identifier.epublicationsrecordune-20120314-092514en
local.publisher.placeNetherlandsen
local.format.startpage1en
local.format.endpage5en
local.identifier.scopusid79955072393en
local.peerreviewedYesen
local.identifier.volume4en
local.contributor.lastnameSharpleyen
local.contributor.lastnameChristieen
dc.identifier.staffune-id:csharpl3en
dc.identifier.staffune-id:dchrist2en
local.profile.orcid0000-0001-7922-4848en
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:9893en
dc.identifier.academiclevelAcademicen
local.title.maintitleThe HPA axis and GABA-Glutamate Systems as Potential Antidepressant Targets in Prostate Canceren
local.output.categorydescriptionC1 Refereed Article in a Scholarly Journalen
local.search.authorSharpley, Chrisen
local.search.authorChristie, David R Hen
local.uneassociationUnknownen
local.year.published2011en
Appears in Collections:Journal Article
Files in This Item:
2 files
File Description SizeFormat 
Show simple item record

Page view(s)

1,174
checked on Jun 23, 2024
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.